| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.003 |